Clinical Trial Update: Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated the pharmacokinetics of sulfasalazine in children with Juvenile Idiopathic Arthritis and was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Azulfidine (sulfasalazine)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Juvenile Rheumatoid | Phase 4 | Status: TERMINATED | Results posted: 2017-02-23